These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 16423064)

  • 41. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells.
    Abe M; Uchihashi K; Kazuto T; Osaka A; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y; Kamihira S
    Eur J Haematol; 2008 Sep; 81(3):209-17. PubMed ID: 18510697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus.
    Henriques A; Inês L; Couto M; Pedreiro S; Santos C; Magalhães M; Santos P; Velada I; Almeida A; Carvalheiro T; Laranjeira P; Morgado JM; Pais ML; da Silva JA; Paiva A
    Cell Immunol; 2010; 264(1):97-103. PubMed ID: 20553755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells.
    Mesquita D; de Melo Cruvinel W; Araujo J; Pucci F; Salmazi K; Kallas E; Andrade L
    Scand J Rheumatol; 2011 Jan; 40(1):41-50. PubMed ID: 20936986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.
    Sfikakis PP; Souliotis VL; Fragiadaki KG; Moutsopoulos HM; Boletis JN; Theofilopoulos AN
    Clin Immunol; 2007 Apr; 123(1):66-73. PubMed ID: 17275413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
    Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
    Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency of regulatory T cells in children with autoimmune neutropenia.
    Nakamura K; Miki M; Mizoguchi Y; Karakawa S; Sato T; Kobayashi M
    Br J Haematol; 2009 Jun; 145(5):642-7. PubMed ID: 19344427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.
    Gómez J; Prado C; López P; Suárez A; Gutiérrez C
    Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis.
    Jiao Z; Wang W; Jia R; Li J; You H; Chen L; Wang Y
    Scand J Rheumatol; 2007; 36(6):428-33. PubMed ID: 18092263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.